The global active humidifier devices market, a critical segment in respiratory care, is anticipated to experience a slight decline over the next decade. According to recent projections, the market, valued at USD 1,264.4 million in 2023, is expected to decrease to USD 1,206.9 million by 2033.
Market Growth and Trends
Historically, the active humidifier devices sector witnessed impressive growth, with a notable CAGR of 28.7%, largely driven by the surge in COVID-19 cases. During the pandemic, these devices were in high demand as they played a crucial role in providing humidified air to individuals requiring respiratory support.
The importance of active humidification in mechanical ventilation is well recognized within the medical community. In response to this need, manufacturers have developed various innovative solutions to cater to patient requirements.
Current Market Challenges
However, the market is currently facing challenges due to a significant decrease in demand as COVID-19 cases have subsided. This downturn is impacting manufacturers, leading to a forecasted decline in market growth. Additionally, active humidifier devices pose risks such as potential infections and water precipitation in circuit tubing, which could prompt the development of more effective medical devices.
Regional Insights
- North America is set to maintain a leading position, with an estimated market share of over 29.4% in 2023. The United States alone is projected to capture a significant share of above 27.8%.
- Europe follows, with an anticipated value share of over 12.2% in 2023. Germany, in particular, holds a notable 4% share of the global market.
- Japan is expected to contribute a value share exceeding 9.7%.
- Conversely, Australia and India are projected to experience negative growth rates of -1.3% and -2.8%, respectively.
- China is expected to exhibit a modest CAGR of 1.5% from 2023 to 2033.
- The United Kingdom is anticipated to see a minimal growth rate of 0.1% CAGR.
Product and Application Insights
- Electronic humidifiers are expected to dominate, holding a projected value share of 55.79%.
- Adults are the primary users, accounting for 87.99% of the market.
- The invasive ventilation segment is a major contributor, representing 47% of market growth.
- Hospitals are the largest end-users, forming 64.5% of the market share.
Explore In-Depth Analysis: Find the Complete Active Humidifier Devices Market Report
Historical Developments and Long-term Strategies
Active humidifier device manufacturers have faced a decline from the historical high growth driven by COVID-19. For instance, Hamilton Medical’s introduction of the H900 active humidifier in 2016 marked a significant advancement in the industry.
To navigate current challenges, key players are focusing on strategic collaborations, partnerships, and acquisitions. Recent notable developments include:
- Vadi Medical Technology’s expansion of its product line with the VH3000-220 Humidifier in January 2021.
- Intersurgical Ltd.’s establishment of a new office in Canada to enhance product availability.
- WILAmed GmbH’s launch of the AIRcon Gen2 Respiratory Humidifier in 2019.
Market Dominance by Key Players in the Market:
- Fisher & Paykel Healthcare Limited
- Koninklijke Philips N.V.(Philips Respironics)
- Vapotherm
- Teleflex Corporation
- ResMed Corporation
- VINCENT MEDICAL HOLDINGS LIMITED
- Armstrong Medical (an Eakin Company)
- Breas Medical AB (Subsidiary of Fosun Pharma)
- BMC Medical Co., Ltd
- Hamilton Medical AG
- SunMed
- WILAmed GmbH
- Flexicare (Group) Limited
- Penlon Limited
- DEAS S.R.L.
- Intersurgical Ltd
- Beijing Aeonmed Co., Ltd.
- Shenyang RMS MEDICAL TECH CO., LTD
- GaleMed Corporation
- Vadi Medical Technology Co, Ltd.
Active Humidifier Devices by Category:
Product Type:
- Heated/electronic Humidifiers
- Bubble Humidifiers
- Accessories
Age Group:
- Adult
- Pediatric
- Neonates
Application:
- Invasive Ventilation
- Non-invasive Ventilation
- nCPAP (Nasal Continuous Positive Airway Pressure)
- Bubble CPAP (Bubble Continuous Positive Airway Pressure)
- High Flow Oxygen Therapy
End User:
- Hospitals
- Less than 100 Beds
- 100-300 Beds
- 300-500 Beds
- 500 Beds and More
- Ambulatory Surgical Centers
- Sleep Centers
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
